prednisone has been researched along with bromochloroacetic acid in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Axelsen, RA; Horn, M; Laird, PP | 1 |
Fanti, PA; Peluso, AM; Piraccini, BM; Tosti, A | 1 |
Bilkenroth, U; Froehner, M; Fuessel, S; Kraemer, K; Linné, C; Meye, A; Schmidt, U; Wirth, MP | 1 |
Li, XQ; Zhan, HQ; Zhou, XY; Zhu, XZ | 1 |
4 other study(ies) available for prednisone and bromochloroacetic acid
Article | Year |
---|---|
Intravascular large cell lymphoma: diagnosis on renal biopsy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Doxorubicin; Female; Fluorescent Antibody Technique; Humans; Immunoenzyme Techniques; Keratins; Kidney; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Prednisone; Proteinuria; S100 Proteins; Vincristine | 1991 |
Nail lichen planus: clinical and pathologic study of twenty-four patients.
Topics: Administration, Oral; Adult; Aged; Cicatrix; Epidermis; Female; Follow-Up Studies; Histiocytes; Humans; Hyalin; Injections, Intralesional; Injections, Intramuscular; Keratins; Lichen Planus; Lymphocytes; Male; Middle Aged; Nail Diseases; Nails; Prednisone; Time Factors; Triamcinolone Acetonide | 1993 |
Quantification of disseminated tumor cells in the bloodstream of patients with hormone-refractory prostate carcinoma undergoing cytotoxic chemotherapy.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Estramustine; Humans; Immunomagnetic Separation; Keratins; Leukocyte Common Antigens; Male; Middle Aged; Mitoxantrone; Neoplasms, Hormone-Dependent; Neoplastic Cells, Circulating; Paclitaxel; Prednisone; Prostate-Specific Antigen; Prostatic Neoplasms; Tumor Cells, Cultured | 2004 |
[Follicular variant of peripheral T-cell lymphoma: a clinicopathologic and genetic study of 2 cases].
Topics: Aged; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis Regulatory Proteins; Chemokine CXCL13; Cyclophosphamide; Doxorubicin; Endostatins; Female; Gene Rearrangement, T-Lymphocyte; Humans; Immunoblastic Lymphadenopathy; Intracellular Signaling Peptides and Proteins; Keratins; Lymphoma, Follicular; Lymphoma, T-Cell; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Oncogene Proteins, Fusion; Prednisone; Programmed Cell Death 1 Receptor; Protein-Tyrosine Kinases; Recombinant Proteins; Remission Induction; Syk Kinase; Vincristine | 2011 |